Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Drug Discovery,Pharmacology
Reference46 articles.
1. Coronaviruses post-SARS: update on replication and pathogenesis;Perlman;Nat Rev Microbiol,2009
2. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet,2020
3. Coronaviruses - drug discovery and therapeutic options;Zumla;Nat Rev Drug Discov,2016
4. Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication;Von Brunn;Curr Opin Virol,2015
5. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu;N Engl J Med,2020
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molecular dynamic simulation of Cyclophilin A in complex with Sanglifehrin A;2024-09-04
2. COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy;European Journal of Clinical Investigation;2024-08-08
3. Cyclophilin inhibition as a strategy for the treatment of human disease;Frontiers in Pharmacology;2024-07-08
4. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147;Cell Communication and Signaling;2024-07-04
5. Impacts of the SARS-CoV-2 Spike Protein on the Innate Immune System: A Review;Cureus;2024-03-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3